ProfileGDS4718 / 204035_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 61% 57% 89% 50% 55% 34% 31% 65% 60% 62% 74% 55% 25% 31% 28% 79% 63% 31% 57% 67% 69% 79% 73% 64% 70% 31% 50% 26% 30% 33% 36% 53% 60% 64% 50% 35% 35% 69% 49% 90% 48% 23% 50% 30% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.1845961
GSM549102patient 115, normal, homogenized [OPG study]5.9506957
GSM549104patient 119, normal, homogenized [OPG study]9.067489
GSM549108patient 138, normal, homogenized [OPG study]5.572450
GSM549119patient 077, normal, homogenized [OPG study]5.8398855
GSM549133patient 032, cancer, homogenized [OPG study]4.6532734
GSM549139patient 042, cancer, homogenized [OPG study]4.5687631
GSM549099patient 107, normal, homogenized [OPG study]6.441965
GSM549109patient 139, normal, homogenized [OPG study]6.1353660
GSM549110patient 046, normal, homogenized [OPG study]6.2691862
GSM549114patient 063, normal, homogenized [OPG study]7.2718974
GSM549122patient 082, normal, homogenized [OPG study]5.8327555
GSM549134patient 033, cancer, homogenized [OPG study]4.3250925
GSM549136patient 036, cancer, homogenized [OPG study]4.5378831
GSM549140patient 044, cancer, homogenized [OPG study]4.4105528
GSM549111patient 047, normal, homogenized [OPG study]7.7372879
GSM549113patient 057, normal, homogenized [OPG study]6.3566963
GSM549132patient 031, cancer, homogenized [OPG study]4.5536531
GSM549137patient 038, cancer, homogenized [OPG study]5.93957
GSM549142patient 047, cancer, homogenized [OPG study]6.6588567
GSM549100patient 110, normal, homogenized [OPG study]6.7199869
GSM549107patient 135, normal, homogenized [OPG study]7.7835879
GSM549115patient 068, normal, homogenized [OPG study]7.2390673
GSM549116patient 072, normal, homogenized [OPG study]6.4202864
GSM549120patient 078, normal, homogenized [OPG study]6.8937770
GSM549131patient 030, cancer, homogenized [OPG study]4.5277531
GSM549118patient 074, normal, homogenized [OPG study]5.5287850
GSM549129patient 027, cancer, homogenized [OPG study]4.3982426
GSM549123patient 088, normal, homogenized [OPG study]4.5255530
GSM549124patient 006, cancer, homogenized [OPG study]4.7325633
GSM549126patient 015, cancer, homogenized [OPG study]4.785936
GSM549128patient 025, cancer, homogenized [OPG study]5.6751853
GSM549103patient 117, normal, homogenized [OPG study]6.1566860
GSM549117patient 073, normal, homogenized [OPG study]6.3688664
GSM549138patient 041, cancer, homogenized [OPG study]5.5140850
GSM549141patient 045, cancer, homogenized [OPG study]4.692135
GSM549130patient 028, cancer, homogenized [OPG study]4.7655135
GSM549101patient 111, normal, homogenized [OPG study]6.8082469
GSM549105patient 128, normal, homogenized [OPG study]5.4666949
GSM549106patient 134, normal, homogenized [OPG study]9.274890
GSM549112patient 048, normal, homogenized [OPG study]5.3917248
GSM549125patient 011, cancer, homogenized [OPG study]4.2834223
GSM549127patient 024, cancer, homogenized [OPG study]5.516950
GSM549135patient 035, cancer, homogenized [OPG study]4.4980830